Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Improving healthcare through diagnostics: the future of IVDs

This article was originally published in Clinica

Executive Summary

Clinicians, hospitals, patients and governments are all striving for improved healthcare. In the US, this has recently taken the form of an ongoing debate about health reform. In addition to expanding access to healthcare services and improving the quality of care, the reform effort aims to slow the growth of healthcare expenditure by "bending the cost curve". Recent estimates suggest that medical errors cost the US approximately $37.6bn each year, approximately $17bn-worth of which are preventable. These errors lead to roughly 70,000-100,000 deaths in US hospitals per year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044989

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel